USPTO 2015–2025 USPTO PatentsView US Corporation

Silk Road Medical, Inc.

USPTO PatentsView assignee record — 80 granted patents across 5 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

80
Total patents granted
5
CPC technology areas
14.3
Avg claims per patent
+5%
5-year filing velocity

The verdict

Silk holds 80 US patents across 5 technology areas — rank #4,436 of 50,000 tracked assignees.

#4,436
of 50,000 US assignees by volume
Top 47%
by Innovation Score (36.1/100)
14.3
avg claims per patent
+5%
filing velocity, last 5 yrs

Portfolio overview

Silk Road Medical, Inc. has been granted 80 US utility patents between 2015 and 2025, placing Silk Road Medical, Inc. at rank #4,436 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Silk Road Medical, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 36.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 41 grants, compared with 39 in the 2015–2019 window — a +5% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Silk Road Medical, Inc.'s 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Silk Road Medical, Inc. against peers pursuing similar technology classes.

How does Silk compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Silk holds 80 patents — placing it at rank #4,436 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Silk's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

051015 20152016201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Silk Road Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 6.3%
2016 7 8.8%
2017 9 11.3%
2018 4 5.0%
2019 14 17.5%
2020 6 7.5%
2021 10 12.5%
2022 5 6.3%
2023 4 5.0%
2024 11 13.8%
2025 5 6.3%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#4,436

Across all tracked assignees

Innovation Score

36.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Silk Road Medical, Inc. hold?
Silk Road Medical, Inc. holds 80 US granted patents filed between 2015 and 2025, spanning 5 technology areas.
What is Silk Road Medical, Inc.'s Innovation Score?
Silk Road Medical, Inc. has an Innovation Score of 36.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Silk Road Medical, Inc. focus on?
Silk Road Medical, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 77 patents. The company has filed patents in 5 CPC subclasses total.
Is Silk Road Medical, Inc.'s patent filing rate increasing or decreasing?
Silk Road Medical, Inc.'s recent filing velocity is +5% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Silk Road Medical, Inc.'s patents?
Silk Road Medical, Inc.'s patents average 14.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Silk Road Medical, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Silk's 80 grants land it in the top 47% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Silk ranks #4,436 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61M — see who else leads that technology area. A61M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov